First Non-Drug Treatment Approved by FDA for Treating Children With ADHD Carlat Reports

First Non-Drug Treatment Approved by FDA for Treating Children With ADHD

The Carlat Child Psychiatry Report, Volume 10, Number 4&5, May 2019
https://www.thecarlatreport.com/newsletter-issue/ccprv10n45/

From The Carlat Child Psychiatry Report, May 2019, Depression in Children and Adolescents

Issue Links: Learning Objectives | Editorial Information

Talia Puzantian, PharmD, BCPP
Joshua Feder, MD

Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In the article we discuss the effectiveness and safety of the first non-drug treatment for ADHD in kids. The FDA has recently granted medical device approval for its external Monarch Trigeminal Nerve Stimulation (eTNS) System for treating kids with ADHD ages 7–12 who are not currently taking medications.

You can't view details of this content, please login or buy subscription here